A downtrend has been apparent in Spero Therapeutics, Inc. (SPRO) lately with too much selling pressure. The stock has declined 9.3% over the past four weeks. However, given the fact that it is now in ...
SPERO THERAPEUTICS ($SPRO) is expected to release its quarterly earnings data on Thursday, March 27th after market close, per Finnhub. Analysts are expecting revenue ...